Table 3. Common adverse events on MyloFrance 1a.
Includes all‐grade adverse events in >15% of patients and grade 3 events in >1% of patients.
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase.
Includes all‐grade adverse events in >15% of patients and grade 3 events in >1% of patients.
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase.